On Friday, Tandem Diabetes Care Inc (NASDAQ: TNDM) opened lower -2.52% from the last session, before settling in for the closing price of $11.52. Price fluctuations for TNDM have ranged from $9.98 to $47.60 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has dropped its sales by -28.23% annually for the last half of the decade. Company’s average yearly earnings per share was noted -39.43% at the time writing.
In an organization with 2650 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 46.95%, operating margin of -17.78%, and the pretax margin is -18.06%.
Tandem Diabetes Care Inc (TNDM) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Medical Devices industry is another important factor to consider. The insider ownership of Tandem Diabetes Care Inc is 0.96%, while institutional ownership is 111.83%. The most recent insider transaction that took place on Mar 07 ’25, was worth 190,966. In this transaction EVP & Chief Operating Officer of this company bought 10,538 shares at a rate of $18.12, taking the stock ownership to the 10,538 shares. Before that another transaction happened on Nov 21 ’24, when Company’s Director sold 30,000 for $31.38, making the entire transaction worth $941,400. This insider now owns 165,190 shares in total.
Tandem Diabetes Care Inc (TNDM) Latest Financial update
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.36 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.41) by 0.05. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.09 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -39.43% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 52.63% during the next five years compared to -28.23% drop over the previous five years of trading.
Tandem Diabetes Care Inc (NASDAQ: TNDM) Trading Performance Indicators
Check out the current performance indicators for Tandem Diabetes Care Inc (TNDM). In the past quarter, the stock posted a quick ratio of 1.88. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.76.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.09, a number that is poised to hit -0.32 in the next quarter and is forecasted to reach -0.86 in one year’s time.
Technical Analysis of Tandem Diabetes Care Inc (TNDM)
Let’s dig in a bit further. During the last 5-days, its volume was 4.64 million. That was better than the volume of 1.68 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 17.51%.
During the past 100 days, Tandem Diabetes Care Inc’s (TNDM) raw stochastic average was set at 8.92%, which indicates a significant decrease from 17.34% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.95 in the past 14 days, which was lower than the 1.00 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $17.63, while its 200-day Moving Average is $25.21. However, in the short run, Tandem Diabetes Care Inc’s stock first resistance to watch stands at $12.21. Second resistance stands at $13.19. The third major resistance level sits at $13.91. If the price goes on to break the first support level at $10.51, it is likely to go to the next support level at $9.79. The third support level lies at $8.81 if the price breaches the second support level.
Tandem Diabetes Care Inc (NASDAQ: TNDM) Key Stats
There are currently 67,569K shares outstanding in the company with a market cap of 758.81 million. Presently, the company’s annual sales total 940,200 K according to its annual income of -96,030 K. Last quarter, the company’s sales amounted to 234,420 K and its income totaled -130,560 K.
